Medical Treatment for Hepatocellular Carcinoma in Japan

Youichi Kawano; Yohei Kaneya; Yuto Aoki; Masato Yoshioka; Akira Matsushita; Tetsuya Shimizu; Junji Ueda; Hideyuki Takata; Nobuhiko Taniai; Tomohiro Kanda; Atsushi Hirakata; Hideyuki Suzuki; Hiroshi Yoshida

doi:10.1272/jnms.JNMS.2022_89-224

This article has now been updated. Please use the final version.

Medical Treatment for Hepatocellular Carcinoma in Japan

Youichi Kawano, Yohei Kaneya, Yuto Aoki, Masato Yoshioka, Akira Matsushita, Tetsuya Shimizu, Junji Ueda, Hideyuki Takata, Nobuhiko Taniai, Tomohiro Kanda, Atsushi Hirakata, Hideyuki Suzuki, Hiroshi Yoshida

Author information

Youichi Kawano
Department of Surgery, Nippon Medical School Chiba-Hokusoh Hospital
Yohei Kaneya
Department of Surgery, Nippon Medical School Chiba-Hokusoh Hospital
Yuto Aoki
Department of Surgery, Nippon Medical School Chiba-Hokusoh Hospital
Masato Yoshioka
Department of Surgery, Nippon Medical School
Akira Matsushita
Department of Surgery, Nippon Medical School
Tetsuya Shimizu
Department of Surgery, Nippon Medical School
Junji Ueda
Department of Surgery, Nippon Medical School Chiba-Hokusoh Hospital
Hideyuki Takata
Department of Surgery, Nippon Medical School Musashikosugi Hospital
Nobuhiko Taniai
Department of Surgery, Nippon Medical School Musashikosugi Hospital
Tomohiro Kanda
Department of Surgery, Nippon Medical School Tamanagayama Hospilal
Atsushi Hirakata
Department of Surgery, Nippon Medical School Tamanagayama Hospilal
Hideyuki Suzuki
Department of Surgery, Nippon Medical School Chiba-Hokusoh Hospital
Hiroshi Yoshida
Department of Surgery, Nippon Medical School

JOURNAL FREE ACCESS Advance online publication

Article ID: JNMS.2022_89-224

DOI https://doi.org/10.1272/jnms.JNMS.2022_89-224

The final version of this article is now available: Vol. 89 (2022), No. 2 pp. 154-160

Details

Abstract

Liver cancer, including hepatocellular carcinoma (HCC), is the fifth most common cause of cancer deaths in Japan. The main treatment options for HCC are surgical resection, liver transplantation, radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and systemic chemotherapy. Here, recent medical treatments for HCC, including surgery, percutaneous ablation, transcatheter arterial chemoembolization/transcatheter arterial embolization, and drug therapy, are reviewed with a focus on Japan.

Corresponding author

Register with J-STAGE for free!